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Abstract
As research progresses towards understanding the role of the amyloid-β (Aβ) in Alzheimer’s
disease, certain aspects of the aggregation process for Aβ are still not clear. In particular, the
accepted constitution of toxic aggregates in neurons has shifted towards small oligomers.
However, the process of forming these oligomers in cells is still not fully clear. Even more
interestingly, it has been implied that cell membranes, and, in particular, anionic lipids within
those membranes, play a key role in the progression of Aβ aggregation, but the exact nature of the
Aβ-membrane interaction in this process is still unknown. In this work, we use a thermodynamic
cycle and umbrella sampling molecular dynamics to investigate dimerization of the 42-residue Aβ
peptide on model zwitterionic dipalmitoylphosphatidylcholine (DPPC) or model anionic
dioleoylphosphatidylserine (DOPS) bilayer surfaces. We determined that Aβ dimerization was
strongly favored through interactions with the DOPS bilayer. Further, our calculations showed that
the DOPS bilayer promoted strong protein-protein interactions within the Aβ dimer, while DPPC
favored strong protein-lipid interactions. By promoting dimer formation and subsequent dimer
release into the solvent, the DOPS bilayer acts as a catalyst in Aβ aggregation through converting
Aβ monomers in solution into Aβ dimers in solution without substantial a free energy cost.
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Introduction
Aberrant protein aggregation and function are the hallmark of a variety of neurodegenerative
disorders found in humans. In Alzheimer’s disease, the neural degeneration that
characterizes this disease has been linked to the aggregation of the amyloid-β (Aβ) peptide,
among other potential aggregate species in neurons1–6. Because of this direct link between
properties of the Aβ peptide and progression of Alzheimer’s disease, the Aβ peptide has
been at the center of extensive biological research over the last 30 years3–6. In particular,
both experimental7–19 and computational20–43 biophysics approaches have focused on this
peptide. Along with many other aspects of Aβ function and activity, the underlying
processes connected to Aβ aggregation have been of substantial interest to researchers. A
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more thorough and clearer understanding of the aggregation pathway from Aβ monomer to
full Aβ fibril is considered to be crucial to development of any targeted therapeutic against
this aspect of Alzheimer’s disease.
As our understanding of the aggregation pathway of Aβ has progressed, our view of Aβ
toxicity in Alzheimer’s disease has evolved7,8,44,45. Initially, it was believed that full Aβ
fibrils or possibly protofibrils were the toxic species in Alzheimer’s disease. However,
further investigation into this process shifted the focus from full fibrils to Aβ oligomers as
the toxic species in neurons7,8,44. Research has shown that these oligomers were able to
disrupt cell function and also disrupt homeostasis across the cell membrane16,45–48.
Further, it has been postulated that these oligomers could form ion channels that would
allow unregulated flow of ions such as calcium across the cell membrane46,47,49,50.
Recent work has also shown that amyloid fibrils are not harmless but can act as reservoirs of
oligomers that can be released if the fibrils are placed under stress51,52. Another interesting
aspect of this system is the underlying structure of oligomers and fibrils. Aβ monomers have
been shown to be mostly random coil in solution27,53 with some transient β-sheet or α-
helical structure. The Aβ monomer structure can be altered by placing the protein in
different environments, promoting either a α-helical or predominantly β-sheet structure54.
However, for Aβ oligomers, the predicted structures of Aβ units are not as clear. The
structures of Aβ oligomers have been shown to be highly variable48,55–58. Structures that
are fibril-like have been observed57,58, as well as completely amorphous structures48,55–
58, or cylindrical structures inserted in cell membranes41,50,59. Thus, it is expected that Aβ
oligomer formation is highly heterogeneous and that ordered structure for Aβ is not locked
until the protein begins to aggregate into a fibril. Even at the fibril level, there is substantial
heterogeneity both on the scale of the fibril as a whole60,61, considering the size and shape
of the fibril, and the predicted underlying structure of the Aβ units within a fibril62–65.
Thus, a better understanding of the physical processes that dictate Aβ oligomerization and
impart such a heterogeneous class of structures to the smallest oligomeric units is essential.
Aβ is a 38–43 amino acid cleavage product of the transmembrane Amyloid Precursor
Protein3–5. Thus, the Aβ peptide contains significant portions of hydrophobic and
hydrophilic residues and shows favorable interactions with cell membranes7,8,10–18,66.
Further, the phenomena dictating the earliest stages of Aβ oligomerization are still not clear.
While experimental work is able to replicate most aspects of in-vivo Aβ aggregation with in-
vitro methods, these studies still require orders-of-magnitude higher Aβ concentrations to
match the aggregation rate of Aβ in cells12,13. While many physical attributes of the
system, such as cellular pH67, salt concentration68, and oxidation of methionine and other
residues69, may play a role in promoting Aβ aggregation in vivo, interactions with cell
membranes have also been postulated to assist in this process. Cell membranes can affect
peptide aggregation through direct electrostatic, hydrophobic or hydrogen bonding
interactions with residues of the peptide7,8,70–72, new partially folded free energy states at
the bilayer surface7,8,70, faster aggregation rates over a two dimensional lipid
surface7,8,70, higher transient peptide concentration as proteins are restricted to the surface,
and lower surface pH due to the attraction of H+ ions in solution to anionic lipid
headgroups11,71,72. All of these factors may play a role in Aβ aggregation on the bilayer
surface. Previous experimental work7–9,11,13–17 has demonstrated that interactions
between Aβ peptides and lipid vesicles strongly promote a conversion to an amyloid-like
structure. Further research7,8,11,13–15,17,18 has shown that mixing anionic lipids with Aβ
peptides leads to a substantial increase in aggregation rate. Finally, extensive interactions
with cell membranes can lead to Aβ pore formation and disruption of ion balance across the
membrane41,46,50,59. While these results demonstrate the importance of protein-lipid
interactions in Aβ aggregation, one shortcoming of these methods is the lack of resolution
that results from the low concentration of Aβ necessary to prevent substantial aggregation
Davis and Berkowitz Page 2













during the experiment. Thus, it is unclear what the aggregation state of Aβ is during these
investigations using cell membranes. Further work with more detailed methods will be
necessary to understand the particulars of atomic-level interactions during Aβ aggregation at
the membrane surface.
Towards this end, we use molecular dynamics (MD) simulations to study the earliest step in
Aβ aggregation: formation of a dimer. Computational studies have been used with great
success to study Aβ structure at the monomer20,22–24,26–30,32,34–39,43,56, small
oligomer21,25,28,29,33,39,40,43,56, and fibril level31,42,43, using either full-length
Aβ20,21,24–27,33–38,40,43 or Aβ fragments22,23,28–32,39,42,43,56. These studies have
used all-atom20–27,29–32,34–38,40,42,43,56 and coarse-grained28,33,39 techniques in
various explicit22,23,26,27,29–38,40,56 or implicit20,21,24,25,28,39,42,43 solvents to
understand this system. More recent works have used advanced computational techniques
such as replica exchange for even more encompassing studies20–25,38,39,43. However, the
extent of computational research34–38,41,59,73 on Aβ-lipid interactions is more restricted.
Most research that has been previously performed on an Aβ-lipid system has involved use of
Aβ monomers34–38,73. These works have also been heavily biased towards studying pre-
inserted Aβ over interactions between Aβ and the bilayer surface. Our previous work with
this system has investigated both the properties of Aβ binding to a model bilayer surface37
and the structure of Aβ on the bilayer surface38. Nevertheless, it is of upmost importance to
begin to expand these studies to the small oligomer structure of Aβ. Work has been done
towards predicting Aβ pore structure within the bilayer41,59, but there is a substantial dearth
of investigations in the specific interactions between Aβ and the surface of cell membranes
that may promote Aβ dimerization. Recent works48,55 have demonstrated the fundamental
role that the Aβ dimer plays as a unit of Aβ aggregation. A more complete understanding of
the physical processes that dictate Aβ dimer formation at the cell surface is necessary to
fully appreciate Aβ aggregation. In this work, we use a thermodynamic cycle to calculate the
free energy of dimerization on a model lipid bilayer for two specific Aβ dimers. The results
of this work, including comprehensive information gleaned from each process of the
thermodynamic cycle, provide molecular level details of Aβ aggregation that can be utilized
towards a greater understanding of the earliest stages of aggregation and the role of cell
membranes in this process.
System and Methods
A full, detailed description of the molecular dynamics procedures used in this work is
provided in the Supplementary Information. In short, two initial dimer structures, an
extended structure (Figure 1a) based on electron microscopy data62 and a hairpin structure
(Figure 1b) derived from NMR data65, were used to calculate a specific dimerization free
energy of the 42 residue Aβ peptide on the surface of either a model zwitterionic
dipalmitoylphosphatidylcholine (DPPC) or model anionic dioleoylphosphatidylserine
(DOPS) bilayer. Further, due to the effect of anionic lipid headgroups on local pH 11, a
neutral Aβ peptide was used in simulations with DOPS to represent the protonation of three
histidine residues. For simulations with DPPC, the physiological charge of −3 was used for
Aβ. In this work, we used a thermodynamic cycle:
(1)
to indirectly calculate ΔGDimerization through direct calculation of ΔGRelease + ΔGDissociation
and use of ΔGBinding values calculated in a previous work37. A depiction of the steps of this
cycle is provided in Figure 2. Using umbrella sampling techniques74,75, we were able to
calculate ΔGRelease + ΔGDissociation and, thus, obtain ΔGDimerization with less systematic
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As described in the Methods section, two initial dimer structures (Figure 1) were used to
calculate a specific dimerization free energy for each Aβ dimer on the bilayer surface. The
first of these structures, the extended dimer (Figure 1a), represents shared C-termini between
two Aβ monomers as predicted from electron microscopy data62. The other structure, the
hairpin dimer (Figure 1b), represents two monomer units from within an Aβ fibril as
determined by NMR65. Thus, intense equilibration is necessary in order to bring each
structure to an equilibrated state on the bilayer surface from which our thermodynamic cycle
calculations could begin. Initially, each structure was equilibrated in solution for a short time
to remove any clashes due to the placement of each monomer in the dimer. Then, the dimer
was placed on the surface of a model lipid bilayer and 150ns MD simulations were
performed. Aside from just equilibration, these 150ns simulations provided an ideal
opportunity to study the stability of the idealized dimer structures on the bilayer surface
versus in solution. Along with the 150ns equilibration on the bilayer surface, we also
continued the short equilibration in solution for an analogous 150ns. By comparing the
evolution of the dimer secondary structure over these equilibration events, it is possible to
study the stability of these specific, ideal dimer structures in either environment. Such a
comparison is presented in the Supplementary Materials. A more thorough discussion and
justification of our choice of these two dimer structures is presented in the Discussion
section.
Thermodynamic Cycle Calculations
Once the dimers were appropriately equilibrated on the bilayer surface, the thermodynamic
cycle calculations could be performed, as demonstrated in Figure 2. The thermodynamic
cycle allowed us to calculate a quantity, ΔGDimerization, that would be very difficult to
calculate directly due to bias created from the choice of reaction coordinate for the pulling
procedure. Further, by calculating ΔGDimerization for two specific dimers instead of one
generic dimer calculation, we can draw more specific conclusions regarding the effect of the
bilayer on this process.
The results of these calculations are summarized in Table I. The dimerization free energy is
calculated using the results as shown in Eq. 1. The free energies presented in Table I are
calculated from the potentials of mean force as described in Supplementary Materials. All
data for the monomer binding step is taken from a previous work37. For a thorough
discussion of the monomer binding process, please see our previous work (note that Aβ
charged is referred to a pH7 and Aβ neutral is referred to as pH5 in the previous work). To
better understand the results in Table I, it is best to present each step individually and then
investigate the calculated dimerization free energy.
Dimer Release from the Bilayer Surface—The release of the Aβ dimer from the
bilayer surface is the third step in our cycle. The potentials of mean force calculated for this
process are given in Figure 3a. From examining both the potential of mean force curves and
the calculated free energies, it is clear that the largest source of distinction between systems
is the charge on the lipid and, therefore, the charge on the peptide. For the charged peptide
on DPPC, the structure of the dimer does not affect the dimer release free energy to any
extent. The free energies for release are similar and the shapes of the potentials are also
similar. Further, the release free energy of the dimer is quite large, implying a very strong
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attraction of the dimer to the bilayer surface. It is interesting that the magnitude of the
release free energy is very close to twice the magnitude of the binding free energy of the
monomer. Also, the potential curve for dimer release is remarkably similar to the monomer
binding curves presented in our earlier work37. This implies that the Aβ dimer is still
preferentially interacting with the interfacial region of the lipid bilayer and the protein-
protein interaction within the dimer is not particularly strong. As the dimer is removed from
the bilayer surface, the peptide-lipid interaction becomes weaker and the peptide-peptide
interaction becomes dominant in order to retain the fidelity of the dimer.
For the neutral Aβ dimer interacting with the DOPS bilayer, the structure of the dimer also
does not effect the dimer release process. Both the extended and hairpin free energies of
dimer release and the potentials of mean force curves are very similar. However, in contrast
to the calculations on DPPC, the release free energy on DOPS is much smaller. Further, the
potential of mean force curves are also more rugged near the free energy minimum. For the
calculations on DPPC, there is a sharp drop in potential when approaching the minimum on
the surface. Yet, on DOPS, there is no sharp drop in the potential and the dimer center of
mass can explore approximately anywhere within a 2nm range of the free energy minimum
without a substantial gain in free energy. All of these aspects of the potential of mean force
curves imply a weaker interaction between the dimer and the bilayer surface. Also, the
location of the free energy minimum provides evidence towards a weaker interaction. While
the free energy minimum is sharply centered around a dimer-bilayer center of mass
separation of 2nm on DPPC, the free energy minimum on DOPS is closer to a 3–3.5nm
center of mass separation. In addition, visual inspection and analogies to our previous
work37,38 show that, on DOPS, the dimer is not strongly interacting with the interfacial
region of the bilayer, as in the case of the dimer on DPPC, but is only transiently interacting
with the headgroup region of the bilayer. Further, the weak free energy of dimer release
demonstrates that the DOPS bilayer biases the system towards strong peptide-peptide
interactions due to weaker protein-lipid interactions. This is in direct contrast to the strong
peptide-lipid and weak peptide-peptide interactions observed on the surface of the DPPC
bilayer.
Along with the analysis of the free energies for dimer release and potential of mean force
curves, we also investigated secondary structure change during the dimer release process.
Use of umbrella sampling for free energy calculations provides 145ns simulations, after 5ns
of equilibration, at a series of dimer-bilayer center of mass separations. By analyzing
secondary structure content within each umbrella, we are able to obtain some insight into
how secondary structure changes as the dimer is released from the bilayer surface. Figure 4a
shows the average β-structure for each of the dimers studied as a function of center of mass
separation. For these calculations, β-content is termed as any residue with β-bridge or β-
sheet structure as determined by DSSP calculation. From this plot, it appears that the amount
of β-content slowly increases as the dimer is removed from the bilayer surface. For the
charged and neutral extended dimer and the neutral hairpin dimer, the average β-content is
approximately the same, between 10–20 residues. For the charged hairpin dimer, the average
β-content is somewhat higher than the same structure with a neutral charge. The average
values for β-content do increase as the dimer is pulled from the surface, it is not clear if
these averages are due to a population of a few structures centered on one average structure,
or if the average is due to a large range of structures over a significant variation in β-content.
To investigate this discrepancy, we calculated free energy surfaces as shown in Figures 4b
and 4c. Figures 4b and 4c show the free energy surface for either the charged extended
dimer (Figure 4b) or the charged hairpin dimer (Figure 4c) as a function of bilayer-dimer
center of mass separation and the number of β-residues. It is obvious from these two plots
that the free energy surfaces are very similar. In both cases, there are no substantial free
energy wells at a given bilayer-center of mass separation. Actually, if the value of bilayer-
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center of mass separation is fixed, there appears to be no favored number of β-residues. This
implies that the secondary structure content for either the extended dimer or the hairpin
dimer is very fluid and there is not a “dominant” structure throughout this process. Also, this
demonstrates that the apparent slight increase in average β-structure as the dimer is removed
from the surface is not significant. It appears that the averages shown in Figure 4a represent
numerical values with little physical significance, as the average is not representative of the
expansive population of potential secondary structures available to the dimer at any dimer-
bilayer center of mass separation. These results are consistent for the dimer release process
of a neutral dimer from the DOPS bilayer as well. What can be concluded from these plots is
that neither lipids on the bilayer surface or water molecules in solution greatly bias the dimer
towards a specific secondary structure but allow for substantial structural flexibility. We also
investigated other secondary structure elements, such as helix content, as it has been
predicted that Aβ can adopt a helical shape when inserted near the bilayer interface 34.
However, as the initial dimer structures were heavily biased towards β-sheets, the extent of
helix structure was negligible and any helix structure that appeared was transient. For the
dimer release process, it appears that the nature of the lipid headgroup significantly affects
the energetics of the release process, but does not bias the system towards a favored
secondary structure content during release.
Dimer Dissociation—The fourth step in the thermodynamic cycle involved calculation of
the free energy required to dissolve the specific Aβ dimer structure in solution, leaving two
non-interacting Aβ monomers. For this calculation, the final Aβ structure from the dimer
release simulation at the largest bilayer-center of mass separation was used as the initial
structure for the dimer dissociation calculation. The dimer was placed in a water box large
enough so that periodic images would not interact at the largest monomer-monomer center
of mass separation. Again, as in the dimer release calculation, umbrella sampling was used
to calculate the potential of mean force curves (Figure 3b) and the ΔGDissociation was
calculated.
From both the ΔGDissociation values and the potential of mean force curves, it is apparent that
a significant amount of free energy is required to dissolve both dimer structures. In solution,
the protein-protein interactions for both dimer structures are very strong, thus leading to the
high free energy of dissociation. Further, the potentials of mean force for all four structures
show a similar shape. The curves are smooth until close to the free energy minimum, where
a sharper drop occurs until a broad free energy minimum is reached. It appears that the two
monomers quickly form an ordered structure once the two monomers are close enough
together.
For the charged extended, neutral extended and charged hairpin dimer structures, both the
ΔGDissociation and the potential of mean forces curves are very similar. This is not surprising
considering the interactions that are stabilizing the dimer. For both extended dimer
structures, the monomers are overlapping from approximately residues 28 – 42 on the C-
terminus. The majority of residues in this region of Aβ are hydrophobic and derive from the
transmembrane portion of the APP peptide before secretase cleavage. As there are no
histidines in this region of the peptide, there should be no difference within the overlapping
regions of the monomer for the charged and neutral dimer. The difference in charge between
these two species is at the N-terminus of the peptide and these regions of the dimer do not
participate in any extensive interprotein interactions. This information also provides an
important baseline for the strength of the hydrophobic interaction at the C-terminus of the
peptide. With ΔGDissociation values between −15kcal/mol and −20kcal/mol, the hydrophobic
interactions and potential hydrogen bonding interactions between the two C-termini of the
monomers provide a substantial stabilizing force for this dimer structure.
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Dimer dissociation for the neutral hairpin dimer is very different from the three other
conditions. While the potential of mean force curve is similar in its shape, the ΔGDissociation
for the neutral dimer is almost 50% larger than the ΔGDissociation of the charged peptide.
Thus, extra interactions are occurring in the neutral dimer that are not available to charged
dimer. As mentioned previously, the difference between the charged and neutral dimer are
the protonation of three histidines (His 6, His 13 and His 14) on the N-terminal tail of Aβ.
While, for the extended dimer, the geometry of the dimer prevents the two N-terminal tails
from interacting, the hairpin dimer promotes N-terminal tail interaction due to the geometry.
As mentioned in more detail in the Supplemental Materials, high temperatures are used in
the equilibration of the hairpin dimer to randomize the structure of the N-terminal tails and
prevent any bias due to the initial structure of the N-terminus. However, once the dimer is
placed on the bilayer surface, it is possible for these tails to interact. Further, because of the
strong interactions occurring between residues 28 – 42 of the two monomers, as
demonstrated by the large ΔGDissociation of the extended dimers, the N-terminal tails are
restricted in their motion. It is also a fallacy to state that these tails are fully charged or
hydrophilic. While the tails do contain the majority of charged or hydrophilic residues in the
peptide, a significant number of amino acids in the N-terminus are still hydrophobic. Thus,
strong interactions could occur between the two N-terminus tails.
To investigate if the N-terminus residues are the cause of the significant difference between
the ΔGDissociation of the charged and neutral hairpin dimers, we calculated center of mass
distances between residues of the two monomers (Figure 5). The reasoning behind these
calculations was to determine if specific interactions were occurring for the neutral peptide
that were not occurring for the charged peptides due to the protonation of the three
histidines. Figure 5 shows four representative plots for these distances. Also, for each pair of
residues, these distances were calculated for three different windows. Each window
corresponds approximately to the free energy minimum and the use of three different
windows shows that these effects are not due the choice of a specific simulation. It can be
observed for three of these plots that, for the neutral dimer, the two analyzed residues are
much closer and the separation between them fluctuates much less, implying a more stable
dimer structure. For His 1,6 and Asp 2,7 (where the first number identifies the monomer and
the second number identifies the residue within that monomer) and His 1,6 and Glu 2,3,
there is a much larger fluctuation for the charged tails. This demonstrates that the N-terminal
tails of the charged dimer show some electrostatic repulsion between the two tails, which
prevents them from coming close enough to form stable electrostatic or hydrogen bonding
interactions. For His 2,14 and Glu 1,11, the fluctuations are less extreme than the first two
examples for the charged dimer, but the extent of fluctuations is still larger than for the
neutral dimer. The smaller fluctuations for these two residues for the charged dimer are
likely due to the geometric restrictions of being closer to the “fixed” points of the
hydrophobic region of the peptides. Further, the neutral dimer shows a smaller distance
between the two residues, implying that a direct electrostatic interaction is formed. Once
again, this illustrates that electrostatic interactions are occurring between residues of the N-
terminal tails that act like a glue to stick the tails together, which helps to form hydrophobic
or hydrogen-bonding interactions that are not seen between the two N-terminal tails for the
charged dimer. The interaction between His 1,13 and Asp 2,11 is included to confirm that
this pattern does not hold for all pairs of charged residues on the N-terminal tails. However,
analysis of all pairs of nearby charged residues with His6, His13 and His14 in the N-
terminal tails shows patterns closest to the first three plots shown in Figure 5 for the
majority of pairs. Further, similar analysis was done with some hydrophobic pairs within the
N-terminus. While the results were not as dramatic as the pair distance plots shown in
Figure 5, the neutral dimer did show closer pair distances and less fluctuation then the
charged dimer. These results imply that the much stronger ΔGDissociation for the neutral
hairpin dimer is due to interactions between the N-terminus of the two monomers. They also
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emphasize the importance of the N-terminus and the role of pH and protein charge in the Aβ
aggregation process.
Dimerization on the Bilayer Surface—The value for ΔGDimerization is calculated using
Eq. 1 from the free energy values calculated in this work and a previous work37. Further, in
Table I, a value for ΔGDimerization + 2*ΔGBinding, which can be termed the total dimerization
free energy, is also provided. This second value represents the free energy gain in binding
two non-interacting Aβ monomers in solution into a specific dimer structure on the bilayer
surface. The values for ΔGDimerization show that dimerization on the bilayer surface is
favorable for most conditions. Even for the neutral extended dimer, the free energy gain
upon monomer binding is able to drive a favorable dimerization process. It is important to
consider this total dimerization free energy in comparison to the directly calculated
ΔGDimerization as binding of the monomer to the bilayer surface may be one of the key
aspects of membrane-assisted Aβ aggregation. Overall, these results of the calculations from
the thermodynamic cycle presented in this work demonstrate the effect of the membrane on
multiple aspects of Aβ dimerization process.
Discussion
Justification of Chosen Dimer Structures
The intention of our work was to calculate a ΔGDimerization for specific Aβ dimers on a
membrane surface. We have strived to use two different structures to investigate protein-
lipid interactions at the Aβ dimer level and to use the ΔGDimerization as a tool to differentiate
the effects of lipid and peptide charge on this process. Therefore, one of the first, and most
fundamental, points of discussion in this work is the choice of the two specific dimer
structures. For this work, we are deriving no actual conclusions as to which of the structures
is correct or which structure is most likely within a fibril or an oligomer. Previous work has
demonstrated that the small oligomer structures of Aβ are very heterogeneous, including
structures containing significant β-sheet, α-helix and unstructured sections. Due to the nature
of the thermodynamic cycle chosen for this work, intermediate monomer structures, such as
predominantly α-helical or β-sheet structures, would not effect the conclusions regarding
dimerization free energies of the specific dimer structures that were chosen, as monomer
structure is masked by the nature of the cycle. Because of the significant β-structure formed
by Aβ mixed with anionic lipids11 and the proclivity of Aβ to form fibrils on the membrane
surface9,66, we decided to use β-sheet models for the dimers studied in this work. However,
extension of this work to other potential dimer structures, including dimers with significant
α-helical character that has been observed in studies with Aβ monomers27,76, would be
critical to gaining a better understanding of the structural diversity of Aβ when interacting
with cell membranes.
Our choices for dimer structures were also motivated by the discrete structural differences
between these dimers. The extended dimer is a more solvent-exposed dimer with the N-
terminal sections of the peptide not able to interact. The hairpin dimer is more compact, has
N-terminal sections that are able to interact and has a different potential β-structure as the
two monomers are parallel versus antiparallel in the extended dimer. Direct comparison of
these two dimers allowed us to study both the importance of N-terminus – N-terminus
interactions in dimerization and the inherent stability of the interactions between the C-
terminus regions of the two monomers.
The use of the thermodynamic cycle to calculate ΔGDimerization was another crucial step
necessary to obtain the results presented in this work. Directly calculating a dimerization
free energy on the membrane surface through a method such as umbrella sampling would
suffer from substantial limitations associated with the reaction coordinate and with the
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sampling of the system. First, the reaction coordinate that is chosen for the pulling would
highly bias the system to a particular dimer structure. With the current restrictions to
sampling in all-atom molecular dynamics, pulling together two monomers on the bilayer
surface will not give a global ΔGDimerization but give a path-dependent ΔGDimerization for a
specific structure. However, within our thermodynamic cycle, the choice of reaction
coordinate at each step is more obvious. The reaction coordinate for monomer binding is
explained in a previous work37. Much like in the monomer binding study, the use of the
dimer-bilayer center of mass separation is also a clear reaction coordinate for dimer release.
For dimer dissolution, the reaction coordinate of monomer-monomer center of mass
separation also appears to be fairly apparent. Because the end point of dimer dissolution is
two non-interacting Aβ monomers, using monomer-monomer center of mass separation is
an appropriate reaction coordinate. By using a thermodynamic cycle with more explicit
reaction coordinates, we can calculate a ΔGDimerization for a specific dimer that is reaction
coordinate independent.
As mentioned, another reason for utilizing the thermodynamic cycle was sampling issues. In
a previous work, we observed that interactions with a cell membrane slow down structural
transitions for monomeric Aβ38. This would imply that directly calculating ΔGDimerization
through pulling two monomers together would suffer from this same sampling issue, where
the restrictions of all-atom molecular dynamics would not allow enough conformational
sampling in reasonable simulation times. For the other steps of the thermodynamic cycle, the
conformational sampling issue is not as substantial. The error bars we calculate for our
potentials of mean force are small and the simulations are of significant length, indicating
that these are reasonable calculations for steps of the cycle. Additionally, for these systems,
extensive equilibration is performed before the umbrella sampling to lessen bias due to
initial conditions, but this bias will still exist to some extent. Within each step of the cycle, a
full exploration of conformational space would require advanced MD techniques, such as a
combination of umbrella sampling with replica exchange. However, while more sampling
would be ideal for all steps of this calculation, the penalties for lacking of complete
sampling for dimer release and dimer dissolution are much less significant than for a direct
dimerization free energy calculation.
Dimer Release Process
Within the thermodynamic cycle, each step reveals interesting aspects of this process. A
detailed analysis of monomer binding is provided in our previous work37. For the dimer
release process, what appears to be the deciding factor dictating dimer release is the charge
on the bilayer surface and not the specific dimer structure. On the DPPC surface, both the
extended and hairpin dimer are tightly bound with a very large ΔGRelease. Similar to the
results seen with monomeric Aβ, both the hairpin and extended dimer interact strongly with
the interfacial region of the bilayer. Because of the zwitterionic nature of the
phosphatidylcholine headgroup, lack of repulsion between the Aβ N-termini and the lipid
headgroups allows the hydrophobic portions of the dimer to interact with the interfacial
region of the lipids. Further, comparison of the ΔGBinding and ΔGRelease shows that, as
ΔGRelease is very close to 2*ΔGBinding in magnitude, the monomers within the dimer are not
undergoing strong protein-protein interactions on the membrane surface, but still act similar
to the bound Aβ monomers. Thus, peptide-lipid interactions remain dominant on DPPC.
However, on DOPS, the dimer is more weakly bound to the bilayer surface. From our
simulations with neutral Aβ on DOPS, we found that, in comparison to the dimers on DPPC,
ΔGRelease is much smaller then 2*ΔGBinding. Because the values for ΔGDissociation are large
for the neutral dimer, we can assume that peptide-peptide interactions are favored on DOPS
over much weaker peptide-lipid interactions. On DOPS, the dimer is not acting as two
monomers but is acting as a dimeric unit that binds more weakly to the lipid surface.
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In the dimer dissociation step of the thermodynamic cycle, it appears that the dimer structure
begins to play a more decisive role. From both the ΔGDissociation and free energy profiles, it
is clear that the neutral hairpin dimer has a drastically different dissociation free energy than
either extended dimer. Further, the neutral hairpin dimer dissociation differs from the
charged hairpin dimer; yet, the charged hairpin dimer dissociation is almost exactly
dissociation in the same as the two extended dimer calculations. For the two extended dimer
conditions, the N-termini are physically separated and are not able to interact. As the
difference in charge between the neutral and charged Aβ dimers is localized to the N-
termini, which are non-interacting for the extended dimers, there is no significant difference
in the dissociation calculations for the two extended dimers. However, for the hairpin dimer,
this is not the case. Due to the parallel β-sheet structure of the overlapping hairpins in the
dimer, the N-terminal sections of both monomers are restricted to being in proximity. For
the charged hairpin dimer, electrostatic repulsion between the tails prevents extensive
interaction. Thus, the interactions, either electrostatic, hydrophobic or hydrogen-bond, that
bind the two monomers together for the charged hairpin are isolated to the C-terminal halves
of the monomers, which is the same region of interaction as the extended dimer. This is
clearly seen in the similarities of the ΔGDissociation and free energy profiles of the charged
hairpin and two extended dimers. However, for the neutral hairpin dimer, the charged
histidines in the N-terminal tail of each monomer are now available for favorable
electrostatic interactions with the anionic residues with the opposing monomer. By changing
the N-terminal interaction from unfavorable to favorable and allowing for extensive
electrostatic and hydrophobic interactions amongst the tails, the monomers are more tightly
bound and the magnitude of ΔGDissociation increases significantly.
Our calculations show the importance of N-terminal tail charge state when studying Aβ
peptide oligomerization and raise an important caveat to future experimental and
computational studies of this system. While studies using Aβ fragments, especially C-
terminal fragments, have been very important and necessary to extending our knowledge of
this system, it is important to note that the N-terminal half of Aβ can play a significant role
in this process. If studies are performed to investigate effects of peptide charge on
aggregation, use of the full Aβ peptide will be crucial to obtaining a full understanding of
this system.
Dimerization Free Energy
Using the thermodynamic cycle presented in this work, we have been able to estimate a
dimerization free energy, ΔGDimerization, as presented in Table I. From this calculation, it
appears that the formation of a dimer on the bilayer surface for three different conditions,
the charged extended dimer and both hairpin dimers, is favorable while formation of the
neutral extended dimer is not. However, we believe that this ΔGDimerization is a somewhat
misleading number. While this number would provide insight for dimerization of nascent Aβ
peptides after APP cleavage but before membrane release, it does not describe the effect of a
cell membrane on soluble Aβ. To determine this value, it is best to look at the sum of
ΔGDimerization + 2*ΔGBinding. Considering this value, dimerization is highly favorable for all
potential dimer structures. Nevertheless, it is important to remember that our calculations are
only for thermodynamic properties of the system and not kinetic properties, which may
significantly bias the favored dimer structure for a given Aβ-membrane system. Thus, the
most important result of this ΔGDimerization calculation is that the dimerization free energy
for all dimer structures calculated here are favorable considering the full membrane binding
and membrane-assisted dimerization process.
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The limitations of this work are similar to previous computational studies. Simple one-
dimensional reaction coordinates are not perfect for describing most biological systems and
sampling will continue to be an issue for all-atom molecular dynamics calculations with the
current computing environment. Because of these limitations, we were not able to directly
calculate ΔGDimerization. However, it is our belief that use of the thermodynamic cycle helps
to avoid these issues while still providing us with a substantial amount of data that is helpful
towards understanding this system. In the future, use of coarse-grain, replica exchange or
other techniques that expand the sampling capabilities of molecular dynamics would be
ideal for studying this system and testing our results. The ideal test would be direct
experimental validation of the patterns we observed in our data. Hopefully, experimental
techniques will progress enough in the near future and resolution can be improved to the
extent that direct Aβ protein-protein interactions on the cell surface can be studied. Our
work demonstrates that the interaction between Aβ proteins and lipid membranes during the
aggregation process is a delicate balance that encompasses a variety of interactions, from
hydrophobic to hydrogen-bonding to electrostatic interactions, which dictate the structure
and feasibility of Aβ aggregation on a cell membrane.
Conclusion
From the results presented in this work, it appears that the interactions between small Aβ
aggregates and cell membranes play a significant role in Aβ aggregation. With the
thermodynamic cycle calculations performed here, we demonstrate that Aβ dimers formed
on DPPC lipids are not strong dimers, but are similar to two Aβ monomers with weak
interpeptide interactions and strong peptide-lipid interactions. However, DOPS lipids favor
strong protein-protein interactions and weak protein-lipid interactions during dimerization,
implying that DOPS is more likely than DPPC to promote the formation of viable dimers for
aggregation. In aggregation, we can speculate that Aβ peptides bind to DOPS lipids, where
concentration effects increase local Aβ concentration, thus increasing the probability of two
Aβ peptides coming into contact. Due to the anionic nature of the lipid headgroup, the local
pH drops and Aβ can adopt a neutral charge. The DOPS lipids then promote strong protein-
protein interactions between monomers while weakening protein-lipid interactions during
dimerization. The nascent dimer is free to be released from the bilayer surface while
maintaining very strong peptide-peptide interactions, acting as a seed for further aggregation
in solution, or dimers could accumulate on the membrane surface, leading to fiber formation
on the membrane. The complex interactions between Aβ and the membrane surface
demonstrated in this work imply the importance of both lipid charge and properties of the
Aβ peptide in aggregation.
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Initial structures used for the (a) Extended and (b) Hairpin dimer simulations.
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Representation of the thermodynamic cycle used to approximate the free energy of
dimerization for Aβ42 on a lipid bilayer.
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Potentials of mean force for (a) Aβ dimer release from the lipid surface into solution and (b)
Aβ dimer dissolution in solution.
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(a) Plot of average number of residues with β-structure, where β-structure contains β-Bridge
and β-Sheet residues, as a function of dimer-bilayer center of mass separation for the dimer
release step of the thermodynamic cycle. Also shown are 2D free energy surfaces of number
of residues with β-structure and center of mass separation with free energy in units of kcal/
mol for the (b) Extended charged dimer or (c) Hairpin charged dimer on DPPC.
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Distance measurements between the centers of mass of indicated residues for either charged
or neutral Hairpin dimer in solution. Distances were calculated within the 0.4nm, 0.7nm and
1.0nm umbrellas to show that the explained phenomenona were not due to a specific
structure or initial condition. Amino acids are listed with the monomer number followed by
the residue number on that monomer. For example, Asp2,7 is actually Asp7 on the second
monomer. The plots begin at 5000ps to indicate that the first 5ns were considered
equilibration.
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